Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online December 1, 1999.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Florence Noble1,
- Stephen A. Wank4,
- Jacqueline N. Crawley3,
- Jacques Bradwejn2,
- Kim B. Seroogy5,
- Michel Hamon6, and
- Bernard P. Roques1,1
- 1Institut National de la Santé et de la Recherche Médicale U266, Centre National de la Recherche Scientifique UMR 8600, Université René Descartes, Paris, France (B.P.R., F.N.); 2Royal Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada (J.B.); 3Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, Maryland (J.N.C.); 4National Institutes of Health, Digestive Diseases Branch, Bethesda, Maryland (S.A.W.); 5Department of Anatomy and Neurobiology, Chandler Medical Center, University of Kentucky, Lexington, Kentucky (K.B.S.); and 6Institut National de la Santéet de la Recherche Médicale U288, Faculté de Médecine Pitié-Salpêtrière, Paris, France (M.H.)
Statistics from Altmetric.com
Article usage
In this issue
Jump to section
- Article
- I. Introduction
- II. Characterization of Cholecystokinin (CCK) Receptors
- III. Molecular Biology of CCK Receptors
- IV. Receptor Structure/Function Studies
- V. Radioligands and Binding Assays: Heterogeneity of CCK1 and CCK2 Receptors
- VI. Distribution of CCK Receptors
- VII. Physiological Implications of CCK Receptors
- VIII. Conclusion
- Acknowledgments
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement